Sector Update: Healthcare Stocks Edge Higher Pre-Bell Friday

MT Newswires Live

Aug 21

Healthcare stocks were edging higher pre-bell Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.1% and the iShares Biotechnology ETF (IBB) advancing by 0.6%.

Arbutus Biopharma (ABUS) shares were up more than 9% after the clinical-stage company said it plans to launch a modified Dutch auction tender offer to repurchase up to $230 million of its common shares at between $5 and $5.75 per share in cash.

Aveanna Healthcare Holdings (AVAH) said selling stockholders priced a secondary public offering of 15 million common shares at $11.75 per share. Aveanna Healthcare stock was down nearly 3% premarket.

Werewolf Therapeutics (HOWL) and Ambros Therapeutics entered into an all-stock merger agreement to create a Nasdaq-listed biotech focused on developing neridronate for complex regional pain syndrome type 1, the companies said. Shares of Werewolf were up 146% pre-bell.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/2661939342"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2661939342\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2661939342?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-21 21:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2661939342","market":"hk","top_or_hot":-1,"title":"Sector Update: Healthcare Stocks Edge Higher Pre-Bell Friday","media":"MT Newswires Live","content":"<html><body><p> Healthcare stocks were edging higher pre-bell Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.1% and the <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) advancing by 0.6%.</p><p><a href=\"https://laohu8.com/S/ABUS\">Arbutus Biopharma</a> (ABUS) shares were up more than 9% after the clinical-stage company said it plans to launch a modified Dutch auction tender offer to repurchase up to $230 million of its common shares at between $5 and $5.75 per share in cash.</p><p><a href=\"https://laohu8.com/S/AVAH\">Aveanna Healthcare</a> Holdings (AVAH) said selling stockholders priced a secondary public offering of 15 million common shares at $11.75 per share. Aveanna Healthcare stock was down nearly 3% premarket.</p><p>Werewolf <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (HOWL) and Ambros Therapeutics entered into an all-stock merger agreement to create a Nasdaq-listed biotech focused on developing neridronate for complex regional pain syndrome type 1, the companies said. Shares of Werewolf were up 146% pre-bell.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sector Update: Healthcare Stocks Edge Higher Pre-Bell Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSector Update: Healthcare Stocks Edge Higher Pre-Bell Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-08-21 21:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Healthcare stocks were edging higher pre-bell Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.1% and the <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) advancing by 0.6%.</p><p><a href=\"https://laohu8.com/S/ABUS\">Arbutus Biopharma</a> (ABUS) shares were up more than 9% after the clinical-stage company said it plans to launch a modified Dutch auction tender offer to repurchase up to $230 million of its common shares at between $5 and $5.75 per share in cash.</p><p><a href=\"https://laohu8.com/S/AVAH\">Aveanna Healthcare</a> Holdings (AVAH) said selling stockholders priced a secondary public offering of 15 million common shares at $11.75 per share. Aveanna Healthcare stock was down nearly 3% premarket.</p><p>Werewolf <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (HOWL) and Ambros Therapeutics entered into an all-stock merger agreement to create a Nasdaq-listed biotech focused on developing neridronate for complex regional pain syndrome type 1, the companies said. Shares of Werewolf were up 146% pre-bell.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IBB","symbol_name":"生物科技指数ETF-iShares Nasdaq","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2661939342","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2661939342","pubTimestamp":1787318162,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Healthcare stocks were edging higher pre-bell Friday, with the State Street Health Care Select Sector SPDR ETF  up 0.1% and the iShares Biotechnology ETF  advancing by 0.6%.Arbutus Biopharma  shares were up more than 9% after the clinical-stage company said it plans to launch a modified Dutch auction tender offer to repurchase up to $230 million of its common shares at between $5 and $5.75 per share in cash.Aveanna Healthcare Holdings  said selling stockholders priced a secondary public offering of 15 million common shares at $11.75 per share. Aveanna Healthcare stock was down nearly 3% premarket.Werewolf Therapeutics  and Ambros Therapeutics entered into an all-stock merger agreement to create a Nasdaq-listed biotech focused on developing neridronate for complex regional pain syndrome type 1, the companies said. Shares of Werewolf were up 146% pre-bell.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IBB":"生物科技指数ETF-iShares Nasdaq","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","HOWL":"Werewolf Therapeutics, Inc.","BK4139":"生物科技","XLV":"健康照护类股ETF-SPDR","HCSG":"Healthcare Svcs Group Inc","XBI":"SPDR S&P Biotech ETF","BK4581":"高盛持仓","ABUS":"Arbutus Biopharma Corporation","BK4585":"ETF&股票定投概念","LABU":"三倍做多标普生物-Direxion","BK4588":"碎股","BK4137":"综合支持服务","BK4196":"保健护理服务","AVAH":"Aveanna Healthcare Holdings Inc.","BK4539":"次新股","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC"},"translate_title":"行业更新：医疗保健股周五盘前小幅走高","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IBB":1,"HCSG":1.5,"XBI":0.6,"LABU":0.6,"HOWL":1,"XLV":1.5,"AVAH":1,"ABUS":1},"content_text":"Healthcare stocks were edging higher pre-bell Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.1% and the iShares Biotechnology ETF (IBB) advancing by 0.6%.Arbutus Biopharma (ABUS) shares were up more than 9% after the clinical-stage company said it plans to launch a modified Dutch auction tender offer to repurchase up to $230 million of its common shares at between $5 and $5.75 per share in cash.Aveanna Healthcare Holdings (AVAH) said selling stockholders priced a secondary public offering of 15 million common shares at $11.75 per share. Aveanna Healthcare stock was down nearly 3% premarket.Werewolf Therapeutics (HOWL) and Ambros Therapeutics entered into an all-stock merger agreement to create a Nasdaq-listed biotech focused on developing neridronate for complex regional pain syndrome type 1, the companies said. Shares of Werewolf were up 146% pre-bell.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}